<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01156519</url>
  </required_header>
  <id_info>
    <org_study_id>09/12-I</org_study_id>
    <nct_id>NCT01156519</nct_id>
  </id_info>
  <brief_title>Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)</brief_title>
  <acronym>ACIC</acronym>
  <official_title>Detection of Infra-clinic Cortisol Adenoma (ACIC) in a Population of Android Obese With High Metabolic Risk: Contribution of Salivary Cortisol at 23 Hours</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to assess the sensitivity of the salivary cortisol dosage
      at 23 hours compared to the serum cortisol dosage at 8 am after overnight 1-mg dexamethasone
      suppression test (Suppression of serum cortisol &lt;1.8 μg/dL ) as the reference method for the
      detection of ACIC in obese subjects
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Number of patients with a serum cortisol &gt; 18 ng/ml reached
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with positive salivary cortisol dosage among patients with positive serum cortisol dosage</measure>
    <description>The main objective of the study is to assess the sensitivity of the salivary cortisol dosage at 23 hours compared to the serum cortisol dosage at 8 am after overnight 1-mg dexamethasone suppression test as the reference method for the detection of ACIC in obese subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with negative salivary cortisol dosage among patients with negative serum cortisol dosage</measure>
    <description>To evaluate specificity, negative predictive value, positive predictive value and diagnostic accuracy of salivary cortisol compared to serum cortisol at 8 am after overnight 1-mg dexamethasone suppression test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparing the results of salivary cortisol dosage and serum cortisol dosage</measure>
    <description>To evaluate concordance between salivary cortisol dosage and serum cortisol dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparing the results of the two salivary samples</measure>
    <description>To evaluate the concordance of the two salivary samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with metabolic complications of obesity among patients with ACIC</measure>
    <description>To evaluate the link between ACIC and metabolic complications of obesity (insulin resistance, IFG, type 2 diabetes, NAFLD…)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with severe type 2 diabetes among patients with ACIC</measure>
    <description>To evaluate the relationship between ACIC and severity of type 2 diabetes, if established.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">514</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Salivary cortisol</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Salivary Cortisol</intervention_name>
    <description>Day 1: 1st salivary cortisol at 23 hours
Day 2: 2nd salivary cortisol at 23 hours and administration of dexamethasone (for overnight 1-mg dexamethasone suppression test)
Day 3: serum cortisol at 8 am
Between Day 4 and Month 3: if serum cortisol at 8 am &gt; 18ng/mL:
Cortisol for 24 hours
dexamethasone suppression test (2mg/j during 2 days)
Cortisol and ACTH cycle
Noriodocholesterol scintigraphy</description>
    <arm_group_label>Salivary cortisol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (≥18 years)

          -  Signed informed consent

          -  Subjects affiliated with an appropriate social security system

          -  Body mass index above 30 kg/m2 and

          -  Pathological waist circumference according to criteria of NCEP ATPIII (men : 94 cm and
             women : 80 cm)

        Exclusion Criteria:

          -  Pregnancy

          -  Sepsis

          -  Recent surgery (less than 30 days)

          -  Any recent severe acute conditions requiring hospitalisation (less than 30 days)

          -  Recent use (&lt; 7 days) of oral steroids, inhaled, dermal, collyrium, infiltration

          -  Long-term oral corticosteroids

          -  Nicotinic substitute or per os licorice in 2 weeks before the inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertrand CARIOU, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2010</study_first_submitted>
  <study_first_submitted_qc>July 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 5, 2010</study_first_posted>
  <last_update_submitted>July 21, 2014</last_update_submitted>
  <last_update_submitted_qc>July 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infra-clinic cortisol adenoma</keyword>
  <keyword>Salivary cortisol</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

